Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37885 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Biomedical Research Review 

Subcommittee. 

Date: October 17, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, Conference Room 3002, 5635 

Fishers Lane, Rockville, MD 20852. 

Contact Person: Philippe Marmillot, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, National Institute on Alcohol 

Abuse and Alcoholism, National Institutes of 

Health, 5635 Fishers Lane, Room 2017, 

Bethesda, MD 20892, 301–443–2861, 

marmillotp@mail.nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Neuroscience Review 

Subcommittee. 

Date: October 24, 2017. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, Terrace Level Conference Room 

508, 5635 Fishers Lane, Rockville, MD 20852. 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Office of 

Extramural Activities, National Institute on 

Alcohol Abuse and Alcoholism, National 

Institutes of Health, 5635 Fishers Lane, Room 

2081, Rockville, MD 20852, 301–443–0800, 

bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: August 8, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17039 Filed 8–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer 

Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http://

videocast.nih.gov). 

A portion of the National Cancer 

Advisory Board meeting will be closed 

to the public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board. 

Date: September 12, 2017. 

Open: 1:00 p.m. to 2:55 p.m. 

Agenda: Acting Director’s and program 

reports and presentations; business of the 

Board. 

Closed: 3:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Room 

TE406 & 408, Rockville, MD 20850 (Virtual 

Meeting). 

Contact Person: Paulette S. Gray, Ph.D., 

Executive Secretary, Division of Extramural 

Activities, National Cancer Institute—Shady 

Grove, National Institutes of Health, 9609 

Medical Center Drive, Room 7W444, 

Bethesda, MD 20892, 240–276–6340, grayp@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NCI-Shady Grove campus. Visitors 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: NCAB: http:// 

deainfo.nci.nih.gov/advisory/ncab/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 8, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17037 Filed 8–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Scientific Advisory Committee on 

Alternative Toxicological Methods; 

Announcement of Meeting; Request 

for Comments 

SUMMARY: This notice announces a 

meeting of the Scientific Advisory 

Committee on Alternative Toxicological 

Methods (SACATM). SACATM advises 

the Interagency Coordinating Committee 

on the Validation of Alternative 

Methods (ICCVAM), the National 

Toxicology Program (NTP) Interagency 

Center for the Evaluation of Alternative 

Toxicological Methods (NICEATM), and 

the Director of the National Institute of 

Environmental Health Sciences (NIEHS) 

and NTP regarding statutorily mandated 

duties of ICCVAM and activities of 

NICEATM. The meeting is open to the 

public, and registration is requested for 

both public attendance and oral 

comment and required to access the 

webcast. Information about the meeting 

and registration is available at http://

ntp.niehs.nih.gov/go/32822. 

DATES: 

Meeting: September 18–19, 2017; it 

begins 9:00 a.m. Eastern Daylight Time 

(EDT) each day and continues until 

adjournment. 

Written Public Comment 

Submissions: Deadline is September 11, 

2017. 

Registration for Oral Comments: 

Deadline is September 11, 2017. 

Registration for the meeting and to 

View Webcast: Deadline is September 

19, 2017. 


sradovich on DSK3GMQ082PROD with NOTICES
37886 Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 

Registration to view the meeting via 

the webcast is required. 

ADDRESSES: 

Meeting Location: Natcher Conference 

Center, Building 45, Room E1 & E2, 

National Institutes of Health, Bethesda, 

MD 20984. 

Meeting Web page: The preliminary 

agenda, registration information, and 

background materials should be posted 

at http://ntp.niehs.nih.gov/go/32822 by 

August 15, 2017. 

Webcast: The meeting will be 

webcast; the URL will be provided to 

those who register for viewing. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Mary Wolfe, Designated Federal Official 

for SACATM, Office of Liaison, Policy, 

and Review, Division of NTP, NIEHS, 

P.O. Box 12233, K2–03, Research 

Triangle Park, NC 27709. Phone: 919– 

541–7539, fax: 301–451–6890, email: 

wolfe@niehs.nih.gov. Hand Deliver/ 

Courier address: 530 Davis Drive, Room 

K2130, Morrisville, NC 27560. 

SUPPLEMENTARY INFORMATION: 

Preliminary Agenda and Other 

Meeting Information: A preliminary 

agenda, roster of SACATM members, 

and background materials should be 

available by August 15, 2017, on the 

SACATM meeting Web site (http://

ntp.niehs.nih.gov/go/32822) and 

available upon request from the 

Designated Federal Official. Public 

comments and any additional 

information will be posted when 

available. The meeting’s agenda will 

focus on the US strategic roadmap for 

implementation of new approaches to 

safety evaluation, which is under 

development, and ICCVAM agencies’ 

activities related to the development 

and implementation of alternative 

methods. Following the meeting, 

summary minutes will be prepared and 

available on the SACATM Web site or 

upon request from the Designated 

Federal Official. 

Meeting and Registration: This 

meeting is open to the public with time 

scheduled for oral public comments. 

The public may attend the meeting at 

Natcher Conference Center, where 

attendance is limited only by the space 

available, or view the webcast. 

Registration is required to view the 

webcast; the URL for the webcast will be 

provided in the email confirming 

registration. Individuals who plan to 

attend and/or provide oral comments 

are encouraged to register at http://

ntp.niehs.nih.gov/go/32822 by 

September 11, 2017, to facilitate 

planning for the meeting. Individuals 

are encouraged to access the Web site to 

stay abreast of the most current 

information regarding the meeting. 

Visitor information for those attending 

in person is available at https://

www.nih.gov/about-nih/visitorinformation. Campus access and 

security information is located at 

https://www.nih.gov/about-nih/visitorinformation/campus-access-security. 

Individuals with disabilities who need 

accommodation to participate in this 

event should contact Ms. Robbin Guy at 

phone: 919–541–4363 or email: guyr2@

niehs.nih.gov. TTY users should contact 

the Federal TTY Relay Service at 800– 

877–8339. Requests should be made at 

least five business days in advance of 

the event. 

Request for Comments: Both written 

and oral public input on the agenda 

topics is invited. Written comments 

submitted in response to this notice 

should be received by September 11, 

2017. Comments will be posted on the 

SACATM meeting Web site and persons 

submitting them will be identified by 

their name and affiliation and/or 

sponsoring organization, if applicable. 

Persons submitting written comments 

should include their name, affiliation (if 

applicable), and sponsoring 

organization (if any) with the document. 

Guidelines for public comments are at 

http://ntp.niehs.nih.gov/ntp/about_ntp/ 

guidelines_public_comments_508.pdf. 

Time is allotted during the meeting 

for the public to present oral comments 

on the agenda topics. Public comments 

can be presented in-person at the 

meeting or by teleconference line. There 

are 50 lines for this call; availability is 

on a first-come, first-served basis. The 

lines will be open from 9:00 a.m. until 

adjournment on September 18 and 19; 

although SACATM will receive public 

comments only during the formal public 

comment periods, as indicated on the 

preliminary agenda. Each organization 

is allowed one time slot per agenda 

topic. Each speaker is allotted at least 7 

minutes, which if time permits, may be 

extended to 10 minutes at the discretion 

of the SACATM chair. 

Persons wishing to present oral 

comments are encouraged to register 

using the SACATM meeting registration 

form (http://ntp.niehs.nih.gov/go/32822) 

by September 11, 2017. Registrants 

should indicate the topic(s) on which 

they plan to comment and whether they 

will present comments in-person or via 

the teleconference. The access number 

for the teleconference line for public 

comments will be provided to 

registrants by email prior to the meeting. 

Registrants are requested to, if possible, 

send a copy of their statement to wolfe@

niehs.nih.gov by September 11, 2017, to 

enable review by SACATM, NICEATM, 

ICCVAM, and NIEHS/NTP staff prior to 

the meeting. Written statements can 

supplement and may expand the oral 

presentation. Registration for on-site 

oral comments will also be available on 

the meeting day, although time allowed 

for comments by these registrants may 

be limited and will be determined by 

the number of persons who register at 

the meeting. If registering on-site and 

reading from written text, please bring 

30 copies of the statement for 

distribution and to supplement the 

record. 

Background Information on ICCVAM, 

NICEATM, and SACATM: ICCVAM is 

an interagency committee composed of 

representatives from 16 federal 

regulatory and research agencies that 

require, use, generate, or disseminate 

toxicological and safety testing 

information. ICCVAM conducts 

technical evaluations of new, revised, 

and alternative safety testing methods 

with regulatory applicability and 

promotes the scientific validation and 

regulatory acceptance of toxicological 

and safety-testing methods that more 

accurately assess the safety and hazards 

of chemicals and products and that 

reduce, refine (decrease or eliminate 

pain and distress), or replace animal 

use. The ICCVAM Authorization Act of 

2000 (42 U.S.C. 285l-3) established 

ICCVAM as a permanent interagency 

committee of the NIEHS under 

NICEATM. 

NICEATM administers ICCVAM, 

provides scientific and operational 

support for ICCVAM-related activities, 

and conducts independent validation 

studies to assess the usefulness and 

limitations of new, revised, and 

alternative test methods and strategies. 

NICEATM and ICCVAM work 

collaboratively to evaluate new and 

improved test methods and strategies 

applicable to the needs of U.S. Federal 

agencies. NICEATM and ICCVAM 

welcome the public nomination of new, 

revised, and alternative test methods 

and strategies for validation studies and 

technical evaluations. Additional 

information about ICCVAM and 

NICEATM can be found at http://

ntp.niehs.nih.gov/go/iccvam and http:// 

ntp.niehs.nih.gov/go/niceatm. 

SACATM was established in response 

to the ICCVAM Authorization Act 

[Section 285l-3(d)] and is composed of 

scientists from the public and private 

sectors. SACATM advises ICCVAM, 

NICEATM, and the Director of the 

NIEHS and NTP regarding statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. SACATM 

provides advice on priorities and 

activities related to the development, 

validation, scientific review, regulatory 

acceptance, implementation, and 

national and international 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices 37887 

harmonization of new, revised, and 

alternative toxicological test methods. 

Additional information about SACATM, 

including the charter, roster, and 

records of past meetings, can be found 

at http://ntp.niehs.nih.gov/go/167. 

Dated: August 1, 2017. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2017–17036 Filed 8–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel NIAID Clinical Trial 

Planning Grant (R34), Implementation 

Cooperative Agreement (U01) and SBIR 

Phase II Implementation Cooperative 

Agreement (U44). 

Date: September 12, 2017. 

Time: 10:00 a.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Maryam Feili-Hariri, 

Ph.D., Scientific Review Officer Scientific 

Review Program Division of Extramural 

Activities, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, Rockville, MD 

20852, 240–669–5026, haririmf@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: August 8, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–17040 Filed 8–11–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Notice of Meeting 

Pursuant to Public Law 92–463, 

notice is hereby given that the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

Center for Substance Abuse Prevention 

(CSAP) National Advisory Council will 

meet on August 25, 2017, 10:00 a.m.– 

11:00 a.m., in Rockville, MD. 

The meeting will include the review, 

discussion, and evaluation of grant 

applications reviewed by the Initial 

Review Group, and involve an 

examination of confidential financial 

and business information as well as 

personal information concerning the 

applicants. Therefore, this meeting will 

be closed to the public as determined by 

the Acting Deputy Assistant Secretary 

for Mental Health and Substance Use, in 

accordance with Title 5 U.S.C. 

552b(c)(4) and (c)(6) and 5 U.S.C. App. 

2, Section 10(d). 

Committee Name: Substance Abuse 

and Mental Health Services 

Administration, Center for Substance 

Abuse Prevention National Advisory 

Council. 

Date/Time/Type: August 25, 2017, 

10:00 a.m.–11:00 a.m. (Closed). 

Place: SAMHSA Building, 5600 

Fishers Lane, Rockville, MD 20852. 

Contact: Matthew J. Aumen, 

Designated Federal Officer, SAMHSA/ 

CSAP National Advisory Council, 5600 

Fishers Lane, Rockville, MD 20852, 

Email: Matthew.Aumen@

samhsa.hhs.gov. 

Carlos R. Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2017–17074 Filed 8–11–17; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2017–0194] 

Waterway Suitability Assessment for 

Operation of Liquefied Hazardous Gas 

Terminal; Port Arthur, TX 

AGENCY: Coast Guard, DHS. 

ACTION: Notice and request for 

comments. 

SUMMARY: In accordance with Coast 

Guard regulations, Lynx Terminals LLC 

(Lynx Terminals) has submitted a Letter 

of Intent and Preliminary Waterway 

Suitability Assessment to the Coast 

Guard Captain of the Port, Port Arthur, 

TX (COTP) regarding the company’s 

plans to handle and transport Liquefied 

Hazardous Gas (LHG) at the Port of Port 

Arthur docks in Port Arthur, TX. The 

Coast Guard is notifying the public of 

this proposed increase in LHG marine 

traffic on the Sabine-Neches Waterway 

and is soliciting comments relevant to 

the Coast Guard’s preparation of a Letter 

of Recommendation (LOR) for issue to 

the federal, state or local agency with 

jurisdiction over the proposed facility. 

DATES: Comments and related material 

must be received on or before 

September 13, 2017. 

ADDRESSES: You may submit comments 

identified by docket number USCG– 

2017–0194 using the Federal 

eRulemaking Portal at http://

www.regulations.gov. See the ‘‘Public 

Participation and Request for 

Comments’’ portion of the 

SUPPLEMENTARY INFORMATION section 

below for further instructions on 

submitting comments. 

FOR FURTHER INFORMATION CONTACT: If 

you have questions on this notice, call 

or email Commander Loan T. O’Brien, 

U.S. Coast Guard; telephone 409–723– 

6564, email: Loan.T.O’Brien@uscg.mil. 

SUPPLEMENTARY INFORMATION: 

Public Participation and Request for 

Comments 

We encourage you to submit 

comments and related material in 

response to this notice through the 

Federal eRulemaking Portal at http://

www.regulations.gov. We will consider 

all submissions and may adjust our final 

action based on your comments. If you 

submit a comment, please include the 

docket number for this notice, indicate 

the specific section of this document to 

which each comment applies, and 

provide a reason for each suggestion or 

recommendation. 

We encourage you to submit 

comments through the Federal 


sradovich on DSK3GMQ082PROD with NOTICES